SCHEMBL899482

SCHEMBL899482

Cc1ccc2c(c1)C(c1ccc(O)c(C)c1)(c1ccc(O)c(C)c1)c1cc(C)ccc1-2

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.68
ESR2 Q92731 5/20 0.68
TDP1 Q9NUW8 3/20 0.53
TP53 P04637 2/20 0.53
MAPT P10636 4/20 0.47
MEN1 O00255 3/20 0.47
LMNA P02545 3/20 0.47
KMT2A Q03164 3/20 0.47
NPSR1 Q6W5P4 3/20 0.47
XBP1 P17861 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TRPA1 O75762 1/20 0.41
PKM P14618 2/20 0.40
CNR1 P21554 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40
PDK2 Q15119 2/20 0.38
ALOX15 P16050 3/20 0.37
HSD17B10 Q99714 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18648071 0.88 TRPA1 (0.52) ESR1ESR2TDP1TP53MAPT
SCHEMBL13080604 0.87 ESR1 (0.52) ESR1ESR2TDP1TP53MAPT
SCHEMBL12924695 0.86 ESR1 (0.50) ESR1ESR2TDP1TP53MAPT
SCHEMBL2675832 0.86 ESR1 (0.68) ESR1ESR2TDP1TP53MAPT
SCHEMBL31276113 0.83 ESR1 (0.64) ESR1ESR2TDP1TP53MAPT
SCHEMBL4072602 0.83 ESR1 (0.64) ESR1ESR2TDP1TP53MAPT
SCHEMBL899618 0.82 ESR1 (0.45) ESR1ESR2TDP1TP53MEN1
SCHEMBL900028 0.81 ESR1 (0.45) ESR1ESR2TDP1TP53MAPT
SCHEMBL899538 0.81 ESR1 (0.60) ESR1ESR2TDP1TP53MAPT
SCHEMBL900305 0.81 ESR1 (0.45) ESR1ESR2TDP1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012042058-A1 IMPACT RESISTANCE MODIFIERS FOR EPOXY RESIN COMPOSITIONS SIKA TECHNOLOGY AG (CH) 2012-04-05 WO disclosed
US-20080027244-A1 Method for Manufacturing Aromatic Dicarboxylic Acid JFE CHEMICAL CORPORATION (JP) 2008-01-31 US disclosed
US-20070255075-A1 Aromatic Diamine And Method For Manufacturing Same JFE CHEMICAL CORPORATION (JP) 2007-11-01 US disclosed
EP-1834943-A1 PROCESS FOR PRODUCING AROMATIC DICARBOXYLIC ACID JFE Chemical Corporation (JP) 2007-09-19 EP disclosed
EP-1803705-A1 AROMATIC DIAMINE AND PROCESS FOR PRODUCING THE SAME JFE Chemical Corporation (JP) 2007-07-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027244-A1 Method for Manufacturing Aromatic Dicarboxylic Acid DDC, PAH, ALDH7A1 ESR1 4756/4885ESR2 4811/4885TDP1 828/4885
US-20070255075-A1 Aromatic Diamine And Method For Manufacturing Same AOC1, DDC, PADI1 ESR1 1381/4885ESR2 2044/4885TDP1 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.